Ernesto Callegari

2.2k total citations
29 papers, 1.3k citations indexed

About

Ernesto Callegari is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, Ernesto Callegari has authored 29 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 12 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Ernesto Callegari's work include Pharmacogenetics and Drug Metabolism (13 papers), Drug Transport and Resistance Mechanisms (10 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Ernesto Callegari is often cited by papers focused on Pharmacogenetics and Drug Metabolism (13 papers), Drug Transport and Resistance Mechanisms (10 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Ernesto Callegari collaborates with scholars based in United States, United Kingdom and France. Ernesto Callegari's co-authors include R. Scott Obach, Amit S. Kalgutkar, Yasuhiro Nakai, Deepak Dalvie, Iain Gardner, John P. O’Donnell, Jason Boer, Kirk R. Henne, Shawn Harriman and Christopher L. Shaffer and has published in prestigious journals such as Neurology, Journal of Pharmacology and Experimental Therapeutics and Annals of Oncology.

In The Last Decade

Ernesto Callegari

27 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ernesto Callegari United States	15	421	396	342	187	158	29	1.3k
Ajay Madan United States	20	364 0.9×	561 1.4×	366 1.1×	83 0.4×	80 0.5×	62	1.6k
David A. Tess United States	18	296 0.7×	365 0.9×	477 1.4×	146 0.8×	229 1.4×	45	1.1k
Natilie Hosea United States	16	439 1.0×	549 1.4×	487 1.4×	265 1.4×	156 1.0×	21	1.5k
R. Foti United States	21	408 1.0×	680 1.7×	373 1.1×	146 0.8×	143 0.9×	51	1.3k
Nina Hanke Germany	20	299 0.7×	308 0.8×	193 0.6×	70 0.4×	158 1.0×	40	1.1k
Cuyue Tang United States	25	631 1.5×	839 2.1×	627 1.8×	206 1.1×	213 1.3×	66	2.2k
Kwan Leung United States	23	688 1.6×	316 0.8×	234 0.7×	108 0.6×	53 0.3×	56	1.8k
David D. Christ United States	25	537 1.3×	472 1.2×	335 1.0×	129 0.7×	86 0.5×	49	1.9k
Mark P. Grillo United States	23	371 0.9×	528 1.3×	226 0.7×	71 0.4×	117 0.7×	47	1.4k
Cho‐Ming Loi United States	23	691 1.6×	611 1.5×	615 1.8×	117 0.6×	153 1.0×	44	1.7k

Countries citing papers authored by Ernesto Callegari

Since Specialization

Citations

This map shows the geographic impact of Ernesto Callegari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ernesto Callegari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ernesto Callegari more than expected).

Fields of papers citing papers by Ernesto Callegari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ernesto Callegari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ernesto Callegari. The network helps show where Ernesto Callegari may publish in the future.

Co-authorship network of co-authors of Ernesto Callegari

This figure shows the co-authorship network connecting the top 25 collaborators of Ernesto Callegari. A scholar is included among the top collaborators of Ernesto Callegari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ernesto Callegari. Ernesto Callegari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ke, Alice, Ernesto Callegari, Rajinder Bhardwaj, et al.. (2024). Physiologically-based Pharmacokinetic Modeling for Assessment of the Drug-drug Interaction Potential of Zavegepant (P9-12.006). Neurology. 102(7_supplement_1). 1 indexed citations

Fanti, Riccardo, et al.. (2023). EXPERIMENTAL CHARACTERIZATION OF THE MULTI-DIRECTIONAL BEHAVIOUR OF ANGLE BRACKETS AND HOLD-DOWNS. Institutional Research Information System (Università degli Studi di Trento). 1305–1311. 1 indexed citations

Callegari, Ernesto, Susanna Tse, Angela C. Doran, Theunis C. Goosen, & M. Naveed Shaik. (2023). Physiologically Based Pharmacokinetic Modeling of the Drug–Drug Interaction Between CYP3A4 Substrate Glasdegib and Moderate CYP3A4 Inducers in Lieu of a Clinical Study. The Journal of Clinical Pharmacology. 64(1). 80–93. 2 indexed citations

Nucci, Gianluca, Ernesto Callegari, Susan Zhou, et al.. (2021). End‐to‐end application of model‐informed drug development for ertugliflozin, a novel sodium‐glucose cotransporter 2 inhibitor. CPT Pharmacometrics & Systems Pharmacology. 10(6). 529–542. 9 indexed citations

Spracklin, Douglas K., Danny Z. Chen, Arthur Bergman, Ernesto Callegari, & R. Scott Obach. (2020). Mini‐Review: Comprehensive Drug Disposition Knowledge Generated in the Modern Human Radiolabeled ADME Study. CPT Pharmacometrics & Systems Pharmacology. 9(8). 428–434. 43 indexed citations

Lapham, Kimberly, Ernesto Callegari, Julie Cianfrogna, et al.. (2020). In Vitro Characterization of Ertugliflozin Metabolism by UDP-Glucuronosyltransferase and Cytochrome P450 Enzymes. Drug Metabolism and Disposition. 48(12). 1350–1363. 16 indexed citations

Callegari, Ernesto, Jian Lin, Susanna Tse, Theunis C. Goosen, & Vaishali Sahasrabudhe. (2020). Physiologically‐Based Pharmacokinetic Modeling of the Drug–Drug Interaction of the UGT Substrate Ertugliflozin Following Co‐Administration with the UGT Inhibitor Mefenamic Acid. CPT Pharmacometrics & Systems Pharmacology. 10(2). 127–136. 14 indexed citations

Ji, Changhua, Mausumee Guha, Xu Zhu, et al.. (2019). Enzalutamide and Apalutamide: In Vitro Chemical Reactivity Studies and Activity in a Mouse Drug Allergy Model. Chemical Research in Toxicology. 33(1). 211–222. 31 indexed citations

Bi, Yi‐An, Jian Lin, Sumathy Mathialagan, et al.. (2018). Role of Hepatic Organic Anion Transporter 2 in the Pharmacokinetics ofR- andS-Warfarin: In Vitro Studies and Mechanistic Evaluation. Molecular Pharmaceutics. 15(3). 1284–1295. 42 indexed citations

10.

Nguyen, Hoa Q., Jian Lin, Emi Kimoto, et al.. (2017). Prediction of Losartan-Active Carboxylic Acid Metabolite Exposure Following Losartan Administration Using Static and Physiologically Based Pharmacokinetic Models. Journal of Pharmaceutical Sciences. 106(9). 2758–2770. 13 indexed citations

11.

Nguyen, Huy Quang, Ernesto Callegari, & R. Scott Obach. (2016). The Use of In Vitro Data and Physiologically-Based Pharmacokinetic Modeling to Predict Drug Metabolite Exposure: Desipramine Exposure in Cytochrome P4502D6 Extensive and Poor Metabolizers Following Administration of Imipramine. Drug Metabolism and Disposition. 44(10). 1569–1578. 19 indexed citations

12.

Nguyen, Huy Quang, Emi Kimoto, Ernesto Callegari, & R. Scott Obach. (2016). Mechanistic Modeling to Predict Midazolam Metabolite Exposure from In Vitro Data. Drug Metabolism and Disposition. 44(5). 781–791. 39 indexed citations

13.

Callegari, Ernesto, Amit S. Kalgutkar, Louis Leung, et al.. (2013). Drug Metabolites as Cytochrome P450 Inhibitors: A Retrospective Analysis and Proposed Algorithm for Evaluation of the Pharmacokinetic Interaction Potential of Metabolites in Drug Discovery and Development. Drug Metabolism and Disposition. 41(12). 2047–2055. 25 indexed citations

14.

Miao, Zhuang, Gianluca Nucci, Neeta B. Amin, et al.. (2012). Pharmacokinetics, Metabolism, and Excretion of the Antidiabetic Agent Ertugliflozin (PF-04971729) in Healthy Male Subjects. Drug Metabolism and Disposition. 41(2). 445–456. 102 indexed citations

15.

Callegari, Ernesto, Bimal Malhotra, Peter J. Bungay, et al.. (2011). A comprehensive non‐clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder. British Journal of Clinical Pharmacology. 72(2). 235–246. 111 indexed citations

16.

Liras, Spiros, Stanton F. McHardy, Martin P. Allen, et al.. (2011). Discovery and pharmacological characterization of a selective delta opiate receptor antagonist (CP-646,777). MedChemComm. 2(5). 413–413. 3 indexed citations

17.

Liras, Spiros, Stanton F. McHardy, Martin P. Allen, et al.. (2009). Biaryl piperidines as potent and selective delta opioid receptor ligands. Bioorganic & Medicinal Chemistry Letters. 20(2). 503–507. 12 indexed citations

18.

Liu, Xingrong, Bill J. Smith, Cuiping Chen, et al.. (2006). Evaluation of Cerebrospinal Fluid Concentration and Plasma Free Concentration As a Surrogate Measurement for Brain Free Concentration. Drug Metabolism and Disposition. 34(9). 1443–1447. 129 indexed citations

19.

Kalgutkar, Amit S., Iain Gardner, R. Scott Obach, et al.. (2005). A Comprehensive Listing of Bioactivation Pathways of Organic Functional Groups. Current Drug Metabolism. 6(3). 161–225. 435 indexed citations

20.

Liu, Xingrong, Bill J. Smith, Cuiping Chen, et al.. (2005). Use of a Physiologically Based Pharmacokinetic Model to Study the Time to Reach Brain Equilibrium: An Experimental Analysis of the Role of Blood-Brain Barrier Permeability, Plasma Protein Binding, and Brain Tissue Binding. Journal of Pharmacology and Experimental Therapeutics. 313(3). 1254–1262. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact